Screener
Wave Life Sciences WVE Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $13.16M— | $2.27M-73.9% | $38.25M+317% | —— | —— | ||
| $53.84M+17.4% | $51.29M+18.0% | $47.44M+16.8% | $52.81M+18.3% | $45.87M+11.4% | ||
| $25.36M+40.2% | $24.78M+37.8% | $22.1M+20.4% | $20.9M+29.5% | $18.09M+20.2% | ||
| $79.21M+23.8% | $76.07M+23.8% | $69.54M+17.9% | $73.71M+21.3% | $63.96M+13.7% | ||
| -$66.05M-17.2% | -$73.8M-39.9% | -$31.3M+37.2% | -$56.47M— | -$56.35M+11.8% | ||
| -502%— | -3,248.3%-2,642pp | -81.8%+461pp | —— | —— | ||
| $4.14M+65.3% | $4.45M+94.2% | $5.21M+78.1% | $3.29M-47.7% | $2.5M+17.1% | ||
| -$61.91M-15.0% | -$69.36M-37.4% | -$26.09M+44.4% | -$53.18M— | -$53.85M+12.8% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| -$61.91M-15.0% | -$69.36M-37.4% | -$26.09M+44.4% | -$53.18M— | -$53.85M+12.8% | ||
| -470.5%— | -3,052.6%-2,472pp | -68.2%+443pp | —— | —— | ||
| -$0.30+6.3% | -$0.34-9.7% | -$0.13+55.2% | -$0.29— | -$0.32+31.9% | ||
| -$65.17M-17.4% | -$72.94M-40.6% | -$30.46M+37.8% | -$55.62M— | -$55.5M+11.9% | ||
| -495.3%— | -3,210.6%-2,614pp | -79.6%+454pp | —— | —— | ||
| -$66.05M-17.2% | -$73.8M-39.9% | -$31.3M+37.2% | -$56.47M— | -$56.35M+11.8% |
FAQ
- Is Wave Life Sciences profitable?
- Wave Life Sciences is not currently profitable: it reported a net loss of $210.5M over the trailing twelve months, a -66.5% net margin.
- What is Wave Life Sciences's earnings per share?
- Wave Life Sciences's diluted EPS over the trailing twelve months is $-1.06.
- Where does Wave Life Sciences's income statement data come from?
- Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.